Advanced Materials for Biologics Delivery to Brain Tumors
Material innovation is central to unlocking the therapeutic potential of biologics against many central nervous system diseases, including brain cancer. By engineering carriers with controlled transport, targeting, and release properties, advanced materials can overcome the blood–brain barrier and tumor microenvironment, improving the delivery of ...
Yuran Feng +4 more
wiley +1 more source
Beyond approval: a mechanism-based review of novel anti-tumour agents in cervical cancer and when to use them. [PDF]
Yang C +5 more
europepmc +1 more source
Pancreatic adenocarcinoma (PAAD) remains highly lethal with limited treatment options. This study demonstrates that coixenolide, a bioactive compound from Coix lacryma‐jobi L. and a key component of the clinically approved Kanglaite injection, exhibits enhanced antitumor efficacy in high‐fat diet (HFD)‐induced obese mice bearing PAAD tumors compared to
Kaidi Chen +20 more
wiley +1 more source
Mechanisms of Resistance and Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: A Narrative Review. [PDF]
Li J +13 more
europepmc +1 more source
Macrophage PABPC4‐SPP1 Axis Orchestrates Immunosuppression in Colorectal Cancer
In the CRC microenvironment, macrophage PABPC4 binds to the 3′UTR of SPP1 mRNA to stabilize its expression, thereby sustaining M2‐like immunosuppressive macrophage polarization. Concurrently, this axis suppresses CD8+ T cell effector functions via CD44 signaling, collectively fostering an immunosuppressive niche that drives tumor progression.
Meng Wang +14 more
wiley +1 more source
Aggressive features and immune landscape of macrotrabecular hepatocellular carcinoma. [PDF]
Wu L +6 more
europepmc +1 more source
ABSTRACT Objective This study investigated the expression, prognostic significance, and functional role of α‐L‐iduronidase (IDUA) in clear cell renal cell carcinoma (ccRCC). Methods We performed two‐sample Mendelian randomization using eQTL and ccRCC GWAS data. We analyzed transcriptomic and clinical data from TCGA and GEO cohorts.
Zhangjun Cao +6 more
wiley +1 more source
Composition of immune cells in peripheral blood of patients with leukemia in remission after stem cell transplantation (HSCT) with or without graft-versus-host disease (GvHD): a comparative analysis with healthy donors. [PDF]
Simon VM +13 more
europepmc +1 more source
Cytotoxic T lymphocyte antigen-4 (CTLA-4) als therapeutisches Target in der Tumorimmuntherapie [PDF]
openaire +1 more source

